Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Cameron

Showing results (191-200 of 286) with videos related to

Pageof 29
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 24, 2018
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primaryClaudio Luchini, Antonio Pea, Jun Yu, et al.
Annals of Surgical Oncology|May 29, 2025
Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant TherapyPaul C M Andel, Brady A Campbell, Joseph R Habib, et al.
Annals of Surgical Oncology|April 29, 2014
The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinomaWenchuan Wu, Jin He, John L Cameron, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 23, 2018
Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant ChemotherapyAmmar A Javed, Michael J Wright, Ayat Siddique, et al.
Advances in Radiation Oncology|March 21, 2018
Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancersKathryn J Schunke, Lauren M Rosati, Marianna Zahurak, et al.
Annals of Surgery|June 11, 2003
Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitisJeffrey M Hardacre, Christine A Iacobuzio-Donahue, Taylor A Sohn, et al.
Annals of Surgery|April 12, 2021
Surgical Decision-Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant ChemotherapyJoseph R Habib, Benedict Kinny-Köster, Patrick Bou-Samra, et al.
Annals of Surgery|July 30, 2009
The Clavien-Dindo classification of surgical complications: five-year experiencePierre A Clavien, Jeffrey Barkun, Michelle L de Oliveira, et al.
Indian Journal of Surgical Oncology|June 15, 2012
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancerHanno Matthaei, Seung-Mo Hong, Skye C Mayo, et al.
Annals of Surgical Oncology|May 4, 2011
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancerHanno Matthaei, Seung-Mo Hong, Skye C Mayo, et al.
Pageof 29

Showing results (191-200 of 286) with videos related to

Sort By:
Pageof 29
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 24, 2018
Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primaryClaudio Luchini, Antonio Pea, Jun Yu, et al.
Annals of Surgical Oncology|May 29, 2025
Association Between Adjuvant Therapy and Survival in Resected Pancreatic Ductal Adenocarcinoma After Different Types and Durations of Neoadjuvant TherapyPaul C M Andel, Brady A Campbell, Joseph R Habib, et al.
Annals of Surgical Oncology|April 29, 2014
The impact of postoperative complications on the administration of adjuvant therapy following pancreaticoduodenectomy for adenocarcinomaWenchuan Wu, Jin He, John L Cameron, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 23, 2018
Outcome of Patients with Borderline Resectable Pancreatic Cancer in the Contemporary Era of Neoadjuvant ChemotherapyAmmar A Javed, Michael J Wright, Ayat Siddique, et al.
Advances in Radiation Oncology|March 21, 2018
Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancersKathryn J Schunke, Lauren M Rosati, Marianna Zahurak, et al.
Annals of Surgery|June 11, 2003
Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitisJeffrey M Hardacre, Christine A Iacobuzio-Donahue, Taylor A Sohn, et al.
Annals of Surgery|April 12, 2021
Surgical Decision-Making in Pancreatic Ductal Adenocarcinoma: Modeling Prognosis Following Pancreatectomy in the Era of Induction and Neoadjuvant ChemotherapyJoseph R Habib, Benedict Kinny-Köster, Patrick Bou-Samra, et al.
Annals of Surgery|July 30, 2009
The Clavien-Dindo classification of surgical complications: five-year experiencePierre A Clavien, Jeffrey Barkun, Michelle L de Oliveira, et al.
Indian Journal of Surgical Oncology|June 15, 2012
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancerHanno Matthaei, Seung-Mo Hong, Skye C Mayo, et al.
Annals of Surgical Oncology|May 4, 2011
Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancerHanno Matthaei, Seung-Mo Hong, Skye C Mayo, et al.
Pageof 29